217 related articles for article (PubMed ID: 26840535)
1. The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.
Moretta F; Petronelli F; Lucarelli B; Pitisci A; Bertaina A; Locatelli F; Mingari MC; Moretta L; Montaldo E
Eur J Immunol; 2016 May; 46(5):1271-8. PubMed ID: 26840535
[TBL] [Abstract][Full Text] [Related]
2. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
Steen R; Tjønnfjord GE; Egeland T
J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
[TBL] [Abstract][Full Text] [Related]
4. Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.
Yu XX; Han TT; Xu LL; Chang YJ; Huang XJ; Zhao XY
J Cell Mol Med; 2018 Jun; 22(6):3025-3034. PubMed ID: 29575692
[TBL] [Abstract][Full Text] [Related]
5. Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study.
Jaiswal SR; Bhakuni P; Joy A; Murli N; Bharadwaj P; Zaman S; Nedunchezian M; Chakrabarti S
Biol Blood Marrow Transplant; 2018 Mar; 24(3):542-548. PubMed ID: 29191663
[TBL] [Abstract][Full Text] [Related]
6. Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease.
Kroeze A; van Hoeven V; Verheij MW; Turksma AW; Weterings N; van Gassen S; Zeerleder SS; Blom B; Voermans C; Hazenberg MD
Cytotherapy; 2022 Mar; 24(3):302-310. PubMed ID: 35058143
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids inhibit human hematopoietic stem cell differentiation toward a common ILC precursor.
Quatrini L; Tumino N; Besi F; Ciancaglini C; Galaverna F; Grasso AG; Merli P; Locatelli F; Vacca P; Moretta L
J Allergy Clin Immunol; 2022 May; 149(5):1772-1785. PubMed ID: 34688777
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.
Rutella S; Filippini P; Bertaina V; Li Pira G; Altomare L; Ceccarelli S; Brescia LP; Lucarelli B; Girolami E; Conflitti G; Cefalo MG; Bertaina A; Corsetti T; Moretta L; Locatelli F
J Transl Med; 2014 Sep; 12():240. PubMed ID: 25179788
[TBL] [Abstract][Full Text] [Related]
11. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation.
Gattillo S; Marktel S; Rizzo L; Malato S; Malabarba L; Coppola M; Assanelli A; Milani R; De Freitas T; Corti C; Bellio L; Ciceri F
Transfusion; 2015 Aug; 55(8):1993-2000. PubMed ID: 25721167
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
14. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
[TBL] [Abstract][Full Text] [Related]
15. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
[TBL] [Abstract][Full Text] [Related]
16. [A comparison between immunophenotypes of lymphoid cells from human umbilical cord blood and bone marrow and its significance].
Guo R; Zou P; Zou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):519-22. PubMed ID: 12513712
[TBL] [Abstract][Full Text] [Related]
17. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.
Lundqvist A; Smith AL; Takahashi Y; Wong S; Bahceci E; Cook L; Ramos C; Tawab A; McCoy JP; Read EJ; Khuu HM; Bolan CD; Joo J; Geller N; Leitman SF; Calandra G; Dunbar C; Kurlander R; Childs RW
J Immunol; 2013 Dec; 191(12):6241-9. PubMed ID: 24244025
[TBL] [Abstract][Full Text] [Related]
18. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections.
Miller JS; Prosper F; McCullar V
Blood; 1997 Oct; 90(8):3098-105. PubMed ID: 9376591
[TBL] [Abstract][Full Text] [Related]
20. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells.
Christopherson KW; Uralil SE; Porecha NK; Zabriskie RC; Kidd SM; Ramin SM
Exp Hematol; 2006 Aug; 34(8):1060-8. PubMed ID: 16863912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
